Logo image of ALECP.PA

EUROPACORP (ALECP.PA) Stock Fundamental Analysis

EPA:ALECP - Euronext Paris - Matif - FR0010490920 - Common Stock - Currency: EUR

0.452  -0.01 (-2.38%)

Fundamental Rating

3

Overall ALECP gets a fundamental rating of 3 out of 10. We evaluated ALECP against 44 industry peers in the Entertainment industry. There are concerns on the financial health of ALECP while its profitability can be described as average. ALECP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALECP had positive earnings in the past year.
ALECP had a positive operating cash flow in the past year.
Of the past 5 years ALECP 4 years were profitable.
In the past 5 years ALECP always reported a positive cash flow from operatings.
ALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

ALECP has a Return On Assets of 0.84%. This is comparable to the rest of the industry: ALECP outperforms 56.82% of its industry peers.
With a Return On Invested Capital value of 1.11%, ALECP perfoms like the industry average, outperforming 56.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALECP is below the industry average of 8.11%.
The last Return On Invested Capital (1.11%) for ALECP is well below the 3 year average (5.62%), which needs to be investigated, but indicates that ALECP had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.84%
ROE N/A
ROIC 1.11%
ROA(3y)4.53%
ROA(5y)10.29%
ROE(3y)6392.79%
ROE(5y)N/A
ROIC(3y)5.62%
ROIC(5y)N/A
ALECP.PA Yearly ROA, ROE, ROICALECP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

ALECP's Profit Margin of 2.43% is in line compared to the rest of the industry. ALECP outperforms 59.09% of its industry peers.
In the last couple of years the Profit Margin of ALECP has declined.
ALECP's Operating Margin of 3.22% is in line compared to the rest of the industry. ALECP outperforms 59.09% of its industry peers.
In the last couple of years the Operating Margin of ALECP has declined.
ALECP has a Gross Margin of 35.15%. This is in the lower half of the industry: ALECP underperforms 70.45% of its industry peers.
ALECP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.22%
PM (TTM) 2.43%
GM 35.15%
OM growth 3Y-15.27%
OM growth 5YN/A
PM growth 3Y-79.82%
PM growth 5YN/A
GM growth 3Y-8.27%
GM growth 5Y13.87%
ALECP.PA Yearly Profit, Operating, Gross MarginsALECP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

3

2. Health

2.1 Basic Checks

ALECP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALECP has about the same amount of shares outstanding.
ALECP has more shares outstanding than it did 5 years ago.
ALECP has a better debt/assets ratio than last year.
ALECP.PA Yearly Shares OutstandingALECP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALECP.PA Yearly Total Debt VS Total AssetsALECP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALECP has an Altman-Z score of -1.65. This is a bad value and indicates that ALECP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALECP (-1.65) is worse than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.65
ROIC/WACC0.26
WACC4.31%
ALECP.PA Yearly LT Debt VS Equity VS FCFALECP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

ALECP has a Current Ratio of 1.34. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALECP (1.34) is better than 79.55% of its industry peers.
ALECP has a Quick Ratio of 1.34. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
ALECP has a better Quick ratio (1.34) than 79.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
ALECP.PA Yearly Current Assets VS Current LiabilitesALECP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1260.00% over the past year.
ALECP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -82.55% yearly.
ALECP shows a decrease in Revenue. In the last year, the revenue decreased by -5.77%.
ALECP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -24.98% yearly.
EPS 1Y (TTM)1260%
EPS 3Y-82.55%
EPS 5YN/A
EPS Q2Q%-8120%
Revenue 1Y (TTM)-5.77%
Revenue growth 3Y-5.23%
Revenue growth 5Y-24.98%
Sales Q2Q%-14.72%

3.2 Future

The Earnings Per Share is expected to decrease by -29.00% on average over the next years. This is quite bad
ALECP is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -46.64% yearly.
EPS Next Y-0.92%
EPS Next 2Y-29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-39.23%
Revenue Next 2Y-46.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALECP.PA Yearly Revenue VS EstimatesALECP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ALECP.PA Yearly EPS VS EstimatesALECP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 45.20, which means the current valuation is very expensive for ALECP.
Based on the Price/Earnings ratio, ALECP is valued a bit cheaper than the industry average as 68.18% of the companies are valued more expensively.
ALECP is valuated expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.25, which indicates a rather cheap valuation of ALECP.
ALECP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALECP is cheaper than 93.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ALECP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 45.2
Fwd PE 7.25
ALECP.PA Price Earnings VS Forward Price EarningsALECP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALECP indicates a somewhat cheap valuation: ALECP is cheaper than 65.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.62
ALECP.PA Per share dataALECP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

ALECP's earnings are expected to decrease with -29.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-29%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALECP!.
Industry RankSector Rank
Dividend Yield N/A

EUROPACORP

EPA:ALECP (6/18/2025, 7:00:00 PM)

0.452

-0.01 (-2.38%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-27 2025-05-27
Earnings (Next)12-09 2025-12-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap56.69M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 45.2
Fwd PE 7.25
P/S 1.6
P/FCF N/A
P/OCF 2.5
P/B N/A
P/tB N/A
EV/EBITDA 4.62
EPS(TTM)0.01
EY2.21%
EPS(NY)0.06
Fwd EY13.79%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.18
OCFY39.97%
SpS0.28
BVpS-0.02
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.84%
ROE N/A
ROCE 1.88%
ROIC 1.11%
ROICexc 2.7%
ROICexgc N/A
OM 3.22%
PM (TTM) 2.43%
GM 35.15%
FCFM N/A
ROA(3y)4.53%
ROA(5y)10.29%
ROE(3y)6392.79%
ROE(5y)N/A
ROIC(3y)5.62%
ROIC(5y)N/A
ROICexc(3y)18.2%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.48%
ROCE(5y)5.63%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.69%
ROICexc growth 5YN/A
OM growth 3Y-15.27%
OM growth 5YN/A
PM growth 3Y-79.82%
PM growth 5YN/A
GM growth 3Y-8.27%
GM growth 5Y13.87%
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 2.87
Cap/Depr 126.09%
Cap/Sales 66.38%
Interest Coverage 0.75
Cash Conversion 114.82%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z -1.65
F-Score6
WACC4.31%
ROIC/WACC0.26
Cap/Depr(3y)71.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)33%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1260%
EPS 3Y-82.55%
EPS 5YN/A
EPS Q2Q%-8120%
EPS Next Y-0.92%
EPS Next 2Y-29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.77%
Revenue growth 3Y-5.23%
Revenue growth 5Y-24.98%
Sales Q2Q%-14.72%
Revenue Next Year-39.23%
Revenue Next 2Y-46.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.69%
EBIT growth 3Y-19.7%
EBIT growth 5YN/A
EBIT Next Year149.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.59%
OCF growth 3Y85.22%
OCF growth 5Y-28.94%